https://pmc.ncbi.nlm.nih.gov/articles/PMC10794404/
Vaccination against neoantigens induced in cross-priming cDC1 in vivo - PMC
The conventional type 1 dendritic cells (cDC1) play a pivotal role in protective immunity against pathogens and cancer. However, their low frequency in the...
vaccinationinducedcrossprimingvivo
https://pubmed.ncbi.nlm.nih.gov/35086958/?dopt=Abstract
Microneedle-mediated Intratumoral Delivery of Anti-CTLA-4 Promotes cDC1-dependent Eradication of...
Head and neck squamous cell carcinoma (HNSCC) ranks sixth in cancer incidence worldwide and has a 5-year survival rate of only 63%. Immunotherapies-principally...